Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is ABIRATERONE ACETATE, with a corresponding US DMF Number 31309.
Remarkably, this DMF maintains an Active status since its submission on March 03, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 30, 2017, and payment made on March 06, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II